









This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process which may 
lead to differences between this version and the Version of Record. Please cite this article as 
an 'Accepted Article', doi: 10.1111/apha.12494 
This article is protected by copyright. All rights reserved. 
Received Date: 15-Dec-2014 
Revision Requested: 6 Feb-2015 
Revised Date   : 20-Feb-2015 
Accepted Date: 18-Mar-2015 




Acetylcholine contributes to control the physiological inflammatory response during 
the peri-implantation period   
 
Daniel Paparini1, Soledad Gori2, Esteban Grasso1, Walter Scordo3, Guillermina Calo1,  
Claudia Pérez Leirós1,  Rosanna Ramhorst1* and Gabriela Salamone2* 
 
* Both Senior authors contribute equally to this work 
 
1Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, 
Universidad de Buenos Aires. IQUIBICEN-CONICET. 2Instituto de Medicina Experimental-
IMEX-CONICET, Academia Nacional de Medicina. Buenos Aires.  
3Servicio de Medicina Transfusional, Hospital Italiano de Buenos Aires, Argentina 
 
Running title: Acetylcholine at the maternal-placental interface  
 
 
Corresponding author:  
Rosanna Ramhorst Ph.D 
Laboratory of Immunopharmacology 
School of Sciences, University of Buenos Aires 
Int. Guiraldes N 2160  
Ciudad Universitaria, Pabellón 2 Piso 4. 










This article is protected by copyright. All rights reserved. 
FAX : + 54-11- 4576-3342 




Maternal antigen presenting cells attracted to the pregnant uterus interact with trophoblast 
cells and modulate their functional profile to favor immunosuppressant responses. Non 
neuronal cholinergic system is expressed in human cytotrophoblast cells and in immune 
cells with homeostatic regulatory functions.  
Aim: The aim of this work was to evaluate whether non neuronal acetylcholine conditions 
maternal monocyte and DC migration and activation profiles.  
Methods: We used an in vitro model resembling maternal-placental interface represented by 
the co-culture of human trophoblast cells (Swan-71 cell line) and monocytes or DC cells.  
Results: When cytotrophoblast cells were treated with neostigmine (Neo) to concentrate 
endogenous acetylcholine levels, monocyte migration was increased. In parallel, high levels 
of IL-10 and decreased levels of TNF-α were observed upon interaction of maternal 
monocytes with trophoblast cells. This effect was synergized by Neo and was prevented by 
atropine, a muscarinic acetylcholine receptor antagonist. Similarly, trophoblast cells 
increased the migration of DC independently of Neo treatment, however enhanced IL-10 and 
MCP-1 synthesis in trophoblast-DC co-cultures with no changes in TNF-α and IL-6 was 
observed. In fact, there were no changes in HLA-DR, CD86 or CD83 expression. Finally, 
trophoblast cells treated with Neo increased the expression of two antigen presenting cell-
attracting chemokines, MCP-1, MIP-1α and RANTES through muscarinic receptors and it 
was prevented by atropine. Conclusions: Our present results support a novel role of 
acetylcholine synthesized by trophoblast cells to modulate antigen presenting cell migration 
and activation favoring an immunosuppressant profile that contributes to immune 
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Introduction    
 
Pregnancy involves different immunological stages with a pro-inflammatory or anti-
inflammatory predominant profile depending on the stage of gestation analyzed (Mor 2008; 
Dekel et al 2010). A successful implantation occurs in a regulated pro-inflammatory 
microenvironment that allows tissue remodeling and angiogenesis at the maternal-placental 
interface. After implantation, the predominant pro-inflammatory microenvironment is 
modulated to an anti-inflammatory/tolerogenic profile required for fetal growth (Mor and 
Cardenas 2010).  
The control of the pro/anti-inflammatory microenvironment implies several regulatory and 
tolerogenic circuits at the site of fetal antigen exposure, that might operate all coordinated to 
sustain gestation (Aluvihare et al 2005; Terness et al 2007; Blois et al 2007; Leber et al 
2010). In this sense, trophoblast cells coordinate the selective recruitment of maternal 
immune cells, such as antigen presenting cells (Huang et al 2008; Fraccaroli et al 2009a; 
Fraccaroli et al 2009b; Gomez-Lopez et al 2010; Dekel et al 2010; Harris LK. 2011).   
Particularly, decidual macrophages and dendritic cells (DC), are recruited toward the feto-
maternal interface following a chemokine gradient where they are conditioned by trophoblast 
cells to express an anti-inflammatroy profile contributing to immune homeostasis 
maintenance through immunosuppressant cytokine synthesis (Laskarin et al 2007; Plaks et 
al 2008; Dekel et al 2010). In fact, human DC upon interaction with first trimester trophoblast 
cells were able to increase the frequency of CD4+CD25+Foxp3 cells with suppressor ability 
(Salamone et al 2012). Regarding human maternal monocytes, they are recruited to the 
decidua and differentiate to macrophages with a predominant ‘alternative’ activation profile 
characterized by the clearance of apoptotic cells and the release of immunosuppressant 
mediators (Abrahams et al 2004; Renaud et al 2008; Nagamatsu and Schust 2010). DC and 
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neurotransmitters through autocrine and paracrine circuits under the control of trophoblast 
cells (Abrahams et al 2004; Mor 2006; Fest et al 2007; Renaud et al 2008; Nagamatsu and 
Schust 2010; Harris LK. 2011; Pérez Leirós and Ramhorst 2013; Grasso et al 2014).  
Regarding the neurotransmitters, non neuronal acetylcholine (ACh) is synthesized and 
released mainly by cytotrophoblast cells of human placenta where it regulates placental 
blood flow, facilitates amino acid transport and hormone release (Olubadewo and Rama 
Sastry 1978; Bhuiyan et al 2006; Wessler and Kirkpatrick 2008; Grando et al 2012; Wessler 
et al 2012).  
Previous data have shown that macrophages express choline acetyltransferase (ChAT) 
and synthesize ACh which inhibits the production of pro-inflammatory cytokines (Borovikova 
et al 2000; Wessler and Kirkpatrick 2008). Likewise, human DC express M3, M4 and M5 
muscarinic ACh receptors (mAChRs), ChAT and acetylcholinesterase (AChE), and both ACh 
and the acetylcholine mimetic drug carbachol modulate DC activation and cytokine 
production (Salamone et al 2011). However, the role of ACh as a modulator of the maternal 
immune response during pregnancy is unknown. 
 Taking into account that trophoblast cells condition the profile of the antigen presenting 
cells and ACh can modulate their cytokine production, here we investigated whether ACh 
produced by trophoblast cells conditions the migration and activation profile of antigen 
presenting cells. For that purpose we used an in vitro model resembling maternal-placental 
interface represented by the co-culture of human trophoblast cells (Swan-71 cell line) and 
maternal monocytes or DC cells.  
 
Materials and Methods   
Blood samples 
Blood samples were processed from healthy fertile women, defined as women who had two 
or more previous normal pregnancies without any miscarriage in their clinical records, non-
smokers, who were not under pharmacological treatment for at least 10 days before the day 
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into heparin containing plastic tubes. Studies were approved by the “Academia Nacional de 
Medicina Review Board” and Ethical Committee. All healthy donors provided written 
informed consent for sample collection and subsequent analysis.  
Monocyte isolation and differentiation to dendritic cells  
Peripheral blood mononuclear cells (PBMC) were isolated from individual subjects and 
CD14+ cells separated by positive selection with CD14+ micromagnetic beads (Miltenyi 
Biotec., Bergisch Gladbach, Germany). Cell population purity (>95%) was checked by 
fluorescent-activated cell sorting (FACS) analysis. DC were obtained from monocytes (106 
cells.ml-1) in the presence of 20 ng.ml-1 IL-4 and 20 ng.ml-1 GM-CSF for five days as 
described (Salamone et al 2011; Salamone et al 2012). Differentiated immature DC (>99%) 
were checked by FACS analysis using anti-CD1a mAb. 
Co-cultures  
Trophoblast cells (Swan-71 cell line, derived by telomerase-mediated transformation of a 7-
week cytotrophoblast isolate (Aplin et al 2006; Straszewski-Chavez et al 2009), were kindly 
given by Dr Gil Mor (Yale University, New Haven, USA); cultured in 24-well flat-bottom 
polystyrene plates in complete DMEM:F12/10% FCS (Life Technologies, Buenos Aires, 
Argentina) or with 2% FCS (DMEM 2%) to prepare conditioned media. At 60% confluence, 
adherent trophoblast cells were cultured with DC or Mo (5×105 cells/well) as described 
previously (Salamone et al 2012) (in the presence or absence of 20 µM Neo 
(acetylcholinesterase inhibitor) and 100 nM atropine (AT) or 10 nM carbachol (Carb) during 
24 h. Trophoblast cell viability was not affected in the presence of 20 µM Neo. DC co-
cultures were performed in the presence of IL-4 and GM-CSF to maintain DC differentiated 
profile.  
Collection of trophoblast cells conditioned media 
Swan-71 cells were cultured in 24-well flat-bottom polystyrene plates in complete DMEM 2% 
FCS overnight to obtain conditioned media (CM) in the absence or presence of 20 µM 
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removed during the CM collection procedure, RNA levels were determined and they were 
below the detection limit. CM were collected and were all stored at -20°C until use.  
RT-PCR  
ChAT, AChE, muscarinic receptors (mAChR), and chemokines (MCP-1, MIP-1α and 
RANTES) expression was determined by RT-PCR as previously described (Fraccaroli et al 
2009b; Salamone et al 2011). Briefly, total RNA was isolated (Life Technologies, Grand 
Island, NY, USA), reverse transcription performed (Clontech; Palo Alto, CA) and cDNA 
fragments amplified using 0.1 µM of each primer (sense and antisense) (Table I) and 1 U 
Taq polymerase in a DNA Thermocycler (PerkinElmer/Cetus, Boston, MA, USA). PCR 
products were fractioned on 2% ethidium bromide-stained agarose gels, visualized by 
transilumination and scanned. Densitometry was performed using ImageJ software 
(http://rsb.info.nih.gov/ij/) and results expressed as arbitrary units normalized to GAPDH 
expression.  
Flow cytometry analysis 
Cells were stained with the following mAbs: FITC- or PE-conjugated mAbs directed to CD1a, 
CD14, CD83, CD86, HLA-DR, TNF-α and IL-10. Ten thousand events were acquired in a 
FACS Calibur® cytometer and results were analyzed using WinMDI 2.9 software 
(http://facs.scripps.edu/software.html).  
Measurement of cytokine production 
DC were cultured or not with trophoblast cells in the presence of 20 µM Neo and 100 nM AT 
for 24h at 37 °C. As an additional control trophoblast cell secretion was quantified under 
basal conditions for each mediator. Then, culture supernatants were collected, centrifuged, 
and analyzed for the presence of TNF-α, IL-6, IL-10 and MCP-1 by ELISA (e-Bioscience, 
Los Angeles, CA, USA). 
Migration assays 
Migration assays were performed in 24 Transwell plates across 5 µm polycarbonate 
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in DMEM containing 2% FCS and placed on the upper chamber. The lower chamber 
contained 600 µl of DMEM 2% FCS supplemented with 20 ng.ml-1 IL-4 and 20 ng.ml-1 GM-
CSF; or CM in the presence or not of Neo, which were equally supplemented with IL-4 and 
GM-CSF. After incubation for 4 h at 37°C, cells in the lower chamber were recovered and 
counted with a FACS Calibur. Migration of monocytes was similar to DC except that it was 
performed for 2 h and each well contained 600 µl of DMEM 2% FCS, CM in the presence or 
not of Neo and atropine.  
Western Blotting 
Trophoblast cells (2×106) were cultured for 24 h at 37 °C, washed with PBS supplemented 
with proteases inhibitors and pellets immediately frozen in dry ice. Samples were separated 
by 10% SDS-PAGE, transferred to polyvinylidene difluoride membranes (Sigma-Aldrich) and 
blotted with the indicated antibodies overnight at 4 °C and specific bands revealed with ECL 
(Amersham Biosciences) using mouse monoclonal IgG anti-ChAT (Chemicon International), 
goat polyclonal IgG anti-AChE (Santa Cruz Biotechnologies) and HRP-labeled secondary 
polyclonal antibodies (Sigma-Aldrich). The breast cancer cell line MCF-7 and DC were 
employed as positive controls for AChE and ChAT expression.  
Fluorescence microscopy  
Trophoblast cells (5×104) were grown over glass slides and cultured for 24 h at 37 °C. Cells 
were washed with PBS, fixed with methanol and permeabilized using PBS-1% BSA-0.5% 
saponin buffer during 15 min. Slides were incubated overnight at 4ºC with mouse IgG mAb 
anti-ChAT or goat polyclonal IgG anti-AChE, washed and incubated with FITC-conjugated 
secondary antibodies anti-mouse or anti-goat IgG for 2 h. DAPI staining (Cell Signaling, 
Danvers, MA, USA) was performed for 10 min in darkness and microphotographs acquired 
using a IX71® Olympus inverted fluorescence microscope (Olympus, Center Valley, PA, 
USA) and Micro-Manager Software. Negative control was performed in the absence of anti-
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Statistical analysis 
The significance of the results was analyzed by Student´s t test or Mann-Whitney test for 
nonparametric samples. When multiple comparisons were necessary, the Student-Newman-
Keuls test was used after analysis of variance. Differences between groups were considered 
significant at P<0.05 using the GraphPad Prism4 software (GraphPad, San Diego, CA, 
USA).  
Reagents and Antibodies  
Endotoxin-free reagents and plastic materials were used in all experiments. RPMI-1640 and 
PBS were purchased from HyClone Laboratories (Logan, UT, USA). DMEM was from Life 
Technologies, Argentina. Fetal calf serum (FCS) and penicillin/streptomycin were purchased 
from Invitrogen Life Technologies (Grand Island, NY, USA). 24-well flat bottom polystyrene 
plates, recombinant human interleukin-4 (IL-4), fluorescein isothiocyanate (FITC)- or 
phycoerythrin (PE)-conjugated anti- CD1a, CD14, CD83, CD86, HLA-DR, IL-10, TNF-α and 
control isotype-matched Abs were from BD Pharmingen (San Diego, CA, USA). 
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), atropine 
and carbachol were from Sigma-Aldrich (St. Louis, MO, USA) and neostigmine from 
Phadapharma Laboratories (Buenos Aires, Argentina). Anti-ChAT antibody (MAB5350) was 
from Chemicon International (Ontario, Canada) and anti-AChE antibody (N-19) b (sc-6431) 
was from Santa Cruz Biotechnology (Heidelberg, Germany). Secondary polyclonal IgG 
labeled with HRP were from Sigma-Aldrich (St. Louis, MO, USA) and ECL detection kit from 
Amersham Biosciences (Wauwatosa, USA). 
 
Results  
ACh produced by trophoblast cells induce the migration of maternal monocytes and 
dendritc cells 
Taking into account the relevance of DC and macrophages in the generation of the materno-
placental interface and that they are able to respond to ACh stimulation, we evaluated the 
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monocytes and DC migration and the effect of acetylcholine. For that purpose migration 
assays were performed using CD14+ cells or DC in the presence of CM from trophoblast 
cells cultured with or without neostigmine (Neo), an acetylcholinesterase inhibitor that 
increases endogenous ACh levels, or atropine, a competitive inhibitor of muscarinic ACh 
receptors. As shown in Figure 1A, CM of first trimester trophoblast cells induced a higher 
monocyte migration rate than DMEM medium alone. On the other hand, when trophoblast 
cells were grown in the presence of 20 µM Neo there was an increased monocyte migration 
and the effect was blocked by atropine.  
In migration assays with DC, we observed a marked increase of DC migration when they 
were exposed to trophoblast cell conditioned media (CM) compared with DMEM 2% FCS 
alone (Figure 1B). The treatment of trophoblast cells with Neo could not further increase DC 
migration compared with trophoblast cells alone, which produced enough chemokine levels 
for maximum migration capacity of DC. Atropine (100 nM) had no effect on DC migration 
induced by trophoblast conditioned media obtained in the presence or absence of 
neostigmine (not shown). 
 
ACh modulates the cytokine production from monocyte after the interaction with 
trophoblast cells  
We next investigated if acetylcholine modify the activation profile of monocytes attracted 
towards trophoblast cells (Thaxton and Sharma 2010). Maternal monocytes were co-cultured 
with trophoblast cells in the absence or presence of 20 µM Neo and atropine and after 24 h, 
IL-10 and TNF-α production were quantified by FACS. Figure 2 shows increased IL-10 
production while decreased TNF-α in CD14+ cells after interaction with trophoblast cells and 
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ACh condition DC profile during their interaction with trophoblast cells  
Since the physiological inflammatory response during the implantation shoud be shift toward 
a tolerogenic one, we investigated ACh ability of condition maternal DC to a tolerogenic 
profile. Then, maternal DC were co-cultured with trophoblast cells in the presence of Neo for 
24 h and then cytokine release, activation and maturation markers were quantified. As 
shows Figure 3A trophoblast-DC interaction increased the levels of IL-10 and MCP-1 
production. In parallel, Neo increased the levels of IL-10 and MCP-1 through mAChR in 
these co-cultures but did not modulate IL-6 or TNF-α production. In fact, the expression of 
HLA-DR, CD86 and CD83, markers of DC activation and maturation, showed no changes 
when DC were co-cultured with trophoblast cells in the presence or absence of Neo (Figure 
3B), suggesting that DC in the presence of Neo might be in an immature state producing IL-
10. 
 
Trophoblast cells increase chemokine expression through ACh stimulation 
Taking into account that ACh produced by trophoblast cells increase the migration of 
monocytes and DC, we analyzed the expression of monocyte and DC chemoattractant 
proteins, MCP-1, MIP-1α and RANTES and its modulation by acetylcholine. Trophoblast 
cells treated with 20 µM neostigmine increased the expression of the three chemokines at 
the same extent than elicited by the muscarinic ACh receptor agonist carbachol (10 nM) and 
the effect was inhibited by the competitive inhibitor of muscarinic ACh receptors atropine 
(Figure 4A).  
Finally, to confirm the enodogenous ACh production we explored ChAT and AChE 
expression in the Swan-71 cells by RT-PCR, Western Blot and immunofluorescence 
microscopy. As shown in Figures 4B, both enzymes are expressed in cytotrophoblast cells at 
mRNA and protein level and they were both localized in the cytoplasm as revealed by 
immunofluorescence. In addition, muscarinic acetylcholine receptor expression was 
assessed in Swan-71 cells. Figure 4C shows the expression of M1, M2, M3 and M4 
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The present results suggest that endogenous ACh prodution by trophoblast cells induce 
monocyte and DC migration increassing MCP-1, MIP-1α and RANTES expression. 
 
Discussion             
Successful embryo implantation occurs followed by a local physiological and sterile 
inflammatory response, subsequently redirected towards a tolerogenic predominant profile. 
Consistently, a deregulated persistent inflammatory response during early placentation has 
been associated with pregnancy complications such as spontaneous recurrent abortion and 
preeclampsia (Girardi et al 2006; Kwak-Kim et al 2010; Redman and Sargent 2010; Dekel et 
al 2010). By means of co-cultures of a human first trimester trophoblast cell line with 
monocytes or DC from fertile women, here we present evidence to support that non neuronal 
ACh from trophoblast cells can modulate the migration and condition the activation of CD14+ 
cells and DC profile. These conclusions are based on two main observations. First, through 
endogenous ACh production, trophoblast cells modulate monocyte and DC migration and 
particularly in monocytes is prevented by atropine. Besides, human trophoblast cell line 
Swan-71 increased the expression of antigen presenting cell-attracting chemokines (MCP-1 
and MIP-1α) and RANTES which can also interacts with CCR5 as MIP-1α.   Second, the 
interaction of trophoblast cells with antigen presenting cells in vitro conditions their activation 
profile. DC displayed an increase in the synthesis of anti-inflammatory IL-10 and the 
chemokine MCP-1 by endogenous ACh with no changes in TNF-α and IL-6 in trophoblast-
dendritic cell co-cultures. In parallel, the contact with trophoblast cells and neostigmine, 
CD14+ cells modulate their marker profile to a predominant immunosuppressant phenotype, 
an effect that is prevented by atropine.  
Antigen presenting cells secrete angiogenic factors that induce vascular growth in receptive 
deciduas and shape the cytokine profile at the materno–placental interface (Dominguez et al 
2005; Dekel et al 2010). They have to migrate to the interface and, consistently, several 
factors synthesized by trophoblast cells were proposed to increase DC, monocytes and 
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predominant response, the immune profile characteristic of midgestation (Fest et al 2007; 
Huang et al 2008; Fraccaroli et al 2009a; Fraccaroli et al 2009b; Gomez-Lopez et al 2010; 
Salamone et al 2012; Grasso et al 2014). Interestingly, non neuronal ACh released by 
placental trophoblast cells varies with gestational age with a maximum at 20-22 weeks in 
humans and decreases thereafter (Sastry and Janson 1997; Tayebati et al 1997; Tayebati et 
al 1998; Bhuiyan et al 2006), coincident with the pattern of immunosuppressant predominant 
microenvironment at the maternal-placental interface (Mor and Cardenas 2010). Our results 
are in line with this observation showing that acetylcholine released by cytotrophoblast cells 
not only facilitates monocyte migration but it also modulates monocyte/macrophage 
functional phenotype to favor an immunosuppressant milieu essential for homeostasis 
maintenance. This promoting effect of non neuronal cholinergic system on cell migration has 
been previously shown in other cell types such as  keratinocytes and granulocytes (Wessler 
and Kirkpatrick 2008). Our results indicate that the treatment of trophoblast cells with Neo 
could not further increase DC migration compared with trophoblast cells alone. Considering 
that chemokine expression levels did increase with neostigmine, this result strongly suggests 
that functional chemokine levels released by Tb cells were enough for maximum migration 
capacity of DC.  
Here we have identified monocyte and DC attracting chemokines MCP-1, MIP-1α and 
RANTES as key molecules which synthesis and release by trophoblast cells was synergized 
by non neuronal acetylcholine. MCP-1 is a well known chemoattractant of monocytes and 
macrophages often released with pro-inflammatory cytokines that activate macrophages in 
an inflammatory activation profile (Mosser and Edwards 2008; Biswas et al 2012; Sica and 
Mantovani 2012). Since an enhanced pro-inflammatory reaction would be deleterious for 
placentation and adequate fetal growth, it is conceivable that trophoblast endogenous 
acetylcholine had a dual role by inducing MCP-1 release to attract monocytes and dendritic 
cells, and in parallel it would favor immunosuppressant cytokine production and phenotype 
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The modulatory effect of acetylcholine on dendritic cell functional profile through 
muscarinic ACh receptors has been documented and it appears strongly dependent on their 
maturation status (Liu T et al 2010; Salamone et al 2011). In fact, cholinergic stimuli added 
to mature DC prevented HLA-DR expression and TNF-α production (Salamone et al 2011). 
This observation supports the ability of trophoblast cells to condition or ‘educate’ DC to 
express a tolerogenic profile that contributes to immune homeostasis maintenance at the 
maternal-fetal compartment (Salamone et al 2012). Our present results confirm the 
trophoblast-DC interaction as a permanent regulatory source for immunosuppression and 
provide new evidence on how endogenous acetylcholine modulates this interaction.  
In line with a boosting effect of endogenous acetylcholine in the normal human maternal-
placental interaction, microarray studies of term placenta from women treated with choline 
showed a decrease in the placental and circulating levels of the antiangiogenic factor fms-
like tyrosine kinase-1 (sFLT1), proposed as a preeclampsia risk biomarker (Jiang et al 
2013). The effect was confirmed in a human trophoblast cell line and was associated with an 
enhanced acetylcholine signaling. On the other hand, an early observation made in 
pregnancies complicated by preeclampsia indicated a very low synthesis of ACh in 
trophoblast cells undergoing advanced cell degeneration (Satyanarayana 1986).  
Based on the potential homeostatic role of non-neuronal cholinergic system in human 
placenta and immune cells, as well as the diverse circuits involving antigen presenting cells 
in normal and pathologic pregnancies, our present results support a novel role of 
endogenous acetylcholine synthesized by trophoblast cells to modulate antigen presenting 
cell migration favoring an immunosuppressant profile.  
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Figure Legends 
Figure 1: ACh produced by trophoblast cells induce the migration of maternal 
monocytes and dendritc cells. A) Mo (2x105 cells) were placed on the upper 5 µm 
transwell chamber and the lower chamber contained conditioned media from trophoblast 
cells (Tb) in the presence or absence of 20 µM Neo and 100 nM atropine. Migration was 
allowed for 2 h at 37°C and basal migration was assessed with DMEM 2% FCS (Media). 
Cells recovered from the lower chamber were counted with a FACS Calibur. Values shown 
are X ± S.E.M of different monocyte samples. *P<0.05; **P<0.01 Mann-Whitney. B) 
Migration of DC (2x105 cells) was performed for 4 h at 37°C in 5 µm transwell chambers with 
trophoblast cell conditioned media (Tb) obtained in the presence or absence of 20 µM Neo 
and supplemented with 20 ng.ml-1 IL-4 and 20 ng.ml-1 GM-CSF as indicated in Methods. 










This article is protected by copyright. All rights reserved. 
values were obtained with DMEM 2% FCS (Media). Results shown are X ± S.E.M of 3 
independent experiments with different DC samples. **P<0.01 Mann-Whitney.  
 
Figure 2: ACh modulates the cytokine production from monocyte after the interaction 
with trophoblast cells. Monocytes were co-cultured with trophoblast cells (Mo+Tb) or not 
(Mo) in the presence or absence of 20 µM Neo and 100 nM AT for 24h at 37 °C. Cells were 
analyzed for TNF-α and IL-10 synthesis by FACS. Results are expressed as the percentage 
of CD14+TNF-α+ and CD14+IL-10+ cells and are representative of at least 4 different 
monocyte samples run in duplicates. *P<0.05; **P<0.01 Mann-Whitney. Dot plots 
representative of 4 experiments with different monocyte samples are also shown.  
 
Figure 3: ACh condition DC profile during their interaction with trophoblast cells.  
DC cultures or  DC-Tb co-cultures were carried out alone or in the presence of 20 µM 
Neostigmine (Neo) or with 20 µM Neo and 100 nM AT (Neo+AT) as described in Methods 
and supernatants collected for (A) IL-10, TNF-α MCP-1 or and IL-6 determination by ELISA. 
Values represent X ± S.E.M of at least 3 experiments. *P<0.05; **P<0.01 Mann-Whitney.  
 B) DC cultured with 20 µM Neo (DC+Neo) or co-cultured with trophoblast cells in the 
presence or not of Neo (DC+Tb) and (DC+Tb+Neo) were analyzed by FACS for the 
expression of HLA-DR, CD86 and CD83. The values represent the MFI and are expressed 
as X ± S.E.M. One representative of 3 others run similarly.  
 
Figure 4: Acetylcholine mediates MCP-1, MIP-1α and RANTES expression in 
trophoblast cells. A) Swan-71 cells were cultured in the presence of 20 µM Neostigmine 
(Neo), 20 µM Neo and 100 nM AT (Neo-AT) or with 10 nM Carbachol (Carb), and MCP-1, 
MIP-1α and RANTES mRNA expression levels were determined. Band density was 
quantified with ImageJ, normalized to GAPDH expression and expressed as arbitrary units. 










This article is protected by copyright. All rights reserved. 
Student-t test.  Results shown are X ± S.E.M of 3 independent experiments with different DC 
samples. **P<0.01 Mann-Whitney.  
B) Swan-71 cells were cultured and processed for ChAT and AChE expression as indicated 
in Methods. The mRNA expression of ChAT and AChE was normalized to GAPDH and 
visualized by transilumination. Results are representative of 3 similar experiments. 
Trophoblast cell extracts were separated on 10% SDS-PAGE, blotted with anti-ChAT or anti-
AChE antibodies and bands normalized to β-actin were detected by ECL. Gels are 
representative of 3 others run similarly. The breast cancer cell line MCF-7 and DC are 
shown as positive controls (+) for AChE and ChAT expression respectively. Finally, 
Trophoblast cells (5×104) were grown over glass slides for immunofluorescence studies and 
immunostained with anti-ChAT or AChE and FITC-conjugated secondary antibodies (green 
fluorescence) or DAPI (blue). Microphotographs were acquired using a IX71® Olympus 
inverted fluorescence microscope and are representative of 3 similar experiments. Negative 
control (Negative) was performed with an irrelevant primary antibody. C) M1-M4 muscarinic 
AChR expression was determined by RT-PCR in trophoblast cells and band density was 
quantified with ImageJ, normalized to GAPDH expression and expressed as arbitrary units. 
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Primer sequences 
AChE 
Sense 5`-AACTTTGCCCGCACAGGGGA-3` Annealing T(°C) 
55 Antisense 5`-GCCTCGTCGAGCGTGTCGGT-3
ChAT 
Sense 5`-GGAGATGTTCTGCTGCTATG-3` Annealing T(°C) 
57 Antisense 5`-GGAGGTGAAACCTAGTGGCA-3`
M1 
Sense 5’-GCTCCCCAAATACAGTCAAGAG-3’  Annealing T(°C) 
56 Antisense 5´-CAGCAGCAGGCGAAAGGTGT-3´ 
M2 
Sense 5´-GATGGCCTGGAGCACAACA-3´ Annealing T(°C) 
56 Antisense 5´-GCTGCTTAGTCATCTTCACAATC-3´ 
M3 
Sense 5´-CGAGCAGATGGACCAAGAC-3´  Annealing T(°C) 
56 Antisense 5´-AGGTAGAGTGGCCGTGCTC-3´ 
M4 
Sense 5´-TCCAATGAGTCCAGCTCAGG-3’ Annealing T(°C) 
56 Antisense 5-AGAGCATAGCAGGCAGGGTTG-3‘
M5 
Sense 5’-GGACTATAAGTTCCGATTGGTG-3´ Annealing T(°C) 
56 Antisense 5’-GGTGACTGGGACACACTTG-3’
MCP-1 
Sense 5’-CAGCAGCAAGTGTCCCAAAG-3’ Annealing T(°C) 
64 Antisense 5’-GAGTGAGTGTTCAAGTCTTCGG-3’
MIP-1α 
Sense 5’-TTCAGACTTCAGAAGGACAC-3’ Annealing T(°C) 
62 Antisense 5’-TGAGCAGGTGACGGAATG-3’ 
RANTES 
Sense 5’-TGCTGCTTTGCCTACATTGC-3’ Annealing T(°C) 
64 Antisense 5’-AAGACGACTGCTGGGTTGG-3’
GAPDH 
Sense 5’-TGATGACATCAAGAAGGTGGTGAAG-3’ Annealing T(°C) 
62 Antisense 5’-TCCTTGGAGGCCATGTAGGCCAT-3’ 
 
Table 1. Primer sequences and annealing temperature. (M1-M5 primers were previously 
publicated by Kylie J.Mansfield, British Journal of Pharmacology (2005) 144, 1089–1099) 
 
 
